Indistinguishable genomic profiles and shared prognostic markers in undifferentiated pleomorphic sarcoma and leiomyosarcoma: Different sides of a single coin

Laboratory Investigation

Volumn 89, Issue 6, 2009, Pages 668-675

  Carneiro, Ana ^a,d   Francis, Princy ^a   Bendahl, Pär Ola ^a   Fernebro, Josefin ^a   Åkerman, Mns ^a   Fletcher, Christopher ^b   Rydholm, Anders ^a   Borg, Åke ^a   Nilbert, Mef ^c  

^a LUND UNIVERSITY   (Sweden)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Array CGH; Gene expression; Pleomorphic sarcomas; Prognosis; Soft tissue sarcoma

Indexed keywords

TROPOMYOSIN;

ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE LOCUS; GENE LOSS; GENETIC ANALYSIS; GENETIC SIMILARITY; GENOMICS; HUMAN; HUMAN CELL; LEIOMYOSARCOMA; METASTASIS; MICROARRAY ANALYSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SARCOMA; SOFT TISSUE SARCOMA; TUMOR NECROSIS; UNDIFFERENTIATED PLEOMORPHIC SARCOMA;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN; CLUSTER ANALYSIS; DIAGNOSIS, DIFFERENTIAL; GENE DOSAGE; GENE EXPRESSION PROFILING; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; LEIOMYOSARCOMA; LIPOSARCOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 66549088451     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2009.18     Document Type: Article

References (48)

1. Fletcher CD, Gustafson P, Rydholm A, et al. Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification. J Clin Oncol 2001;19:3045-3050.
2. Fletcher CU, Krishman K, Mertens F (eds). WHO Classification of Tumours; Pathology and Genetics: Tumours of Soft Tissue and Bone. IARC Press: Lyon, France, 2002.
3. Nielsen TO, West RB, Linn SC, et al. Molecular characterisation of soft tissue tumours: a gene expression study. Lancet 2002;359:1301-1307.
4. Segal NH, Pavlidis P, Antonescu CR, et al. Classification and subtype prediction of adult soft tissue sarcoma by functional genomics. Am J Pathol 2003;163:691-700.
5. Francis P, Namlos HM, Muller C, et al. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential. BMC Genomics 2007;8:73.
6. Nakayama R, Nemoto T, Takahashi H, et al. Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma. Mod Pathol 2007;20:749-759.
7. Skubitz KM, Cheng EY, Clohisy DR, et al. Differential gene expression in liposarcoma, lipoma, and adipose tissue. Cancer Invest 2005;23: 105-118.
8. Derre J, Lagace R, Nicolas A, et al. Leiomyosarcomas and most malignant fibrous histiocytomas share very similar comparative genomic hybridization imbalances: an analysis of a series of 27 leiomyosarcomas. Lab Invest 2001;81:211-215.
9. Chibon F, Mariani O, Derre J, et al. A subgroup of malignant fibrous histiocytomas is associated with genetic changes similar to those of well-differentiated liposarcomas. Cancer Genet Cytogenet 2002;139:24-29.
10. Fritz B, Schubert F, Wrobel G, et al. Microarray-based copy number and expression profiling in dedifferentiated and pleomorphic liposarcoma. Cancer Res 2002;62:2993-2998.
11. Ohguri T, Hisaoka M, Kawauchi S, et al. Cytogenetic analysis of myxoid liposarcoma and myxofibrosarcoma by array-based comparative genomic hybridisation. J Clin Pathol 2006;59:978-983.
12. Heidenblad M, Hallor KH, Staaf J, et al. Genomic profiling of bone and soft tissue tumors with supernumerary ring chromosomes using tiling resolution bacterial artificial chromosome microarrays. Oncogene 2006;25:7106-7116.
13. Fletcher CD. Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol 1992;16:213-228.
14. Schurch W, Begin LR, Seemayer TA, et al. Pleomorphic soft tissue myogenic sarcomas of adulthood. A reappraisal in the mid-1990s. Am J Surg Pathol 1996;20:131-147.
15. Oda Y, Miyajima K, Kawaguchi K, et al. Pleomorphic leiomyosarcoma: clinicopathologic and immunohistochemical study with special emphasis on its distinction from ordinary leiomyosarcoma and malignant fibrous histiocytoma. Am J Surg Pathol 2001;25:1030-1038.
16. Hasegawa T, Hasegawa F, Hirose T, et al. Expression of smooth muscle markers in so called malignant fibrous histiocytomas. J Clin Pathol 2003;56:666-671.
17. Hill DA, O'Sullivan MJ, Zhu X, et al. Practical application of molecular genetic testing as an aid to the surgical pathologic diagnosis of sarcomas: a prospective study. Am J Surg Pathol 2002;26:965-977.
18. Bridge JA. Contribution of cytogenetics to the management of poorly differentiated sarcomas. Ultrastruct Pathol 2008;32:63-71.
19. Staaf J, Jonsson G, Ringner M, et al. Normalization of array-CGH data: influence of copy number imbalances. BMC Genomics 2007;8:382.
20. Krzywinski M, Bosdet I, Smailus D, et al. A set of BAC clones spanning the human genome. Nucleic Acids Res 2004;32:3651-3660.
21. Snijders AM, Nowak N, Segraves R, et al. Assembly of microarrays for genome-wide measurement of DNA copy number. Nat Genet 2001;29:263-264.
22. Fernebro J, Francis P, Eden P, et al. Gene expression profiles relate to SS18/SSX fusion type in synovial sarcoma. Int J Cancer 2006;118: 1165-1172.
23. Saal LH, Troein C, Vallon-Christersson J, et al. BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data. Genome Biol 2002;3:SOFTWARE0003.
24. Autio R, Hautaniemi S, Kauraniemi P, et al. CGH-Plotter: MATLAB toolbox for CGH-data analysis. Bioinformatics (Oxford, England) 2003;19:1714-1715.
25. Aguirre AJ, Brennan C, Bailey G, et al. High-resolution characterization of the pancreatic adenocarcinoma genome. Proceedings of the National Academy of Sciences of the United States of America 2004;101:9067-9072.
26. Yang YH, Dudoit S, Luu P, et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002;30:e15.
27. Liu Y, Ringner M. Multiclass discovery in array data. BMC Bioinformatics 2004;5:70.
28. Schoenfeld DA, Richter JR. Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint. Biometrics 1982;38:163-170.
29. Chin SF, Wang Y, Thorne NP, et al. Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers. Oncogene 2007;26:1959-1970.
30. Mandahl N, Fletcher CD, Dal Cin P, et al. Comparative cytogenetic study of spindle cell and pleomorphic leiomyosarcomas of soft tissues: a report from the CHAMP Study Group. Cancer Genet Cytogenet 2000;116:66-73.
31. Mertens F, Fletcher CD, Dal Cin P, et al. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and morphology. Genes Chromosomes Cancer 1998;22:16-25.
32. Wang R, Lu YJ, Fisher C, et al. Characterization of chromosome aberrations associated with soft-tissue leiomyosarcomas by twenty-four-color karyotyping and comparative genomic hybridization analysis. Genes Chromosomes Cancer 2001;31:54-64.
33. Packenham JP, du Manoir S, Schrock E, et al. Analysis of genetic alterations in uterine leiomyomas and leiomyosarcomas by comparative genomic hybridization. Mol Carcinog 1997;19:273-279.
34. Levy B, Mukherjee T, Hirschhorn K. Molecular cytogenetic analysis of uterine leiomyoma and leiomyosarcoma by comparative genomic hybridization. Cancer Genet Cytogenet 2000;121:1-8.
35. Mairal A, Terrier P, Chibon F, et al. Loss of chromosome 13 is the most frequent genomic imbalance in malignant fibrous histiocytomas. A comparative genomic hybridization analysis of a series of 30 cases. Cancer Genet Cytogenet 1999;111:134-138.
36. Weng WH, Lerner M, Grander D, et al. Loss of chromosome 13q is a frequently acquired event in genetic progression of soft tissue sarcomas in the abdominal cavity. Int J Oncol 2005; 26:5-16.
37. Chibon F, Mairal A, Freneaux P, et al. The RB1 gene is the target of chromosome 13 deletions in malignant fibrous histiocytoma. Cancer Res 2000;60:6339-6345.
38. Weaver J, Downs-Kelly E, Goldblum JR, et al. Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms. Mod Pathol 2008;21:943-949.
39. Coindre JM, Hostein I, Maire G, et al. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity. J Pathol 2004;203:822-830.
40. Florenes VA, Maelandsmo GM, Forus A, et al. MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status. J Natl Canc Inst 1994;86:1297-1302.
41. Pollock R, Gilman M. Transcriptional activation: is it rocket science? Proceedings of the National Academy of Sciences of the United States of America 1997;94:13388-13389.
42. Bartel F, Taubert H, Harris LC. Alternative and aberrant splicing of MDM2 mRNA in human cancer. Cancer Cell 2002;2:9-15.
43. Sandberg AA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyosarcoma. Cancer Genet Cytogenet 2005;161:1-19.
44. Lee YF, John M, Edwards S, et al. Molecular classification of synovial sarcomas, leiomyosarcomas and malignant fibrous histiocytomas by gene expression profiling. Br J Cancer 2003;88:510-515.
45. Kawai A, Kondo T, Suehara Y, et al. Global protein-expression analysis of bone and soft tissue sarcomas. Clin Orthop Relat Res 2008;466:2099-2106.
46. Suehara Y, Kondo T, Fujii K, et al. Proteomic signatures corresponding to histological classification and grading of soft-tissue sarcomas. Proteomics 2006;6:4402-4409.
47. Kodach LL, Bleuming SA, Musler AR, et al. The bone morphogenetic protein pathway is active in human colon adenomas and inactivated in colorectal cancer. Cancer 2008;112:300-306.
48. Moore R, Champeval D, Denat L, et al. Involvement of cadherins 7 and 20 in mouse embryogenesis and melanocyte transformation. Oncogene 2004;23:6726-6735.